OpenAI Acquires Pharma Co Orchestra Bio to Build AI Agents for Drug Development
The companies plan to develop AI agents that connect scientific findings with the studies, decisions, and workflows to advance drug candidates.
Discussion
Rejoignez la communauté pour réagir et poser vos questions.
Aucun message pour l'instant. Lancez la discussion !